Peter Kirk

Q: What is Peter Kirk email address?

Email Peter Kirk at peter@sermo.com. This email is the most updated Peter Kirk's email found in 2026.

Q: How to contact Peter Kirk?

To contact Peter Kirk send an email to peter@sermo.com.

CEO at Sermo | New York, New York, United States

About Peter Kirk

Peter Kirk has been at the forefront of healthcare innovation since he took the helm as CEO of Sermo in July 2012. Under his leadership, Sermo has transformed from a traditional services provider into a pioneering solutions platform that leverages deep healthcare domain expertise to deliver unparalleled insights. By acquiring and merging with another entity, Kirk successfully established the world's first global medical social platform, seamlessly integrating traditional market research capabilities with cutting-edge technology. This strategic move not only expanded Sermo’s reach but also enhanced its value proposition, positioning the company as a trusted social network for over 800,000 physicians worldwide.

Kirk's visionary approach has led to the commercialization of a suite of innovative products that cater to the evolving needs of healthcare professionals and organizations. His emphasis on a customer-first approach has fostered a culture of collaboration and engagement, enabling Sermo to harness the collective intelligence of its physician community. This has resulted in groundbreaking research methodologies that drive actionable insights for pharmaceutical companies, healthcare providers, and policymakers alike.

With a robust background in strategy, marketing research, and entrepreneurship, Kirk is adept at navigating the complexities of the healthcare landscape. His expertise in mergers and acquisitions has been instrumental in scaling Sermo’s operations and enhancing its competitive edge. As Sermo continues to expand its influence in the global healthcare market, Kirk remains committed to pushing the boundaries of what’s possible, ensuring that healthcare professionals have access to the insights they need to improve patient outcomes and advance the industry as a whole.

Peter Kirk Work